Abstract:
A composition, method and test device for determining the presence of leukocytes, esterase or protease in a test sample are disclosed. The composition comprises an ester which is hydrolyzed in the presence of leukocyte, esterase, or protease to form a reaction product which couples with a diazonium salt to produce a detectable color change. The composition further comprises the salt of an alkaline earth metal which stabilizes the composition during manufacture and prevents the occurrence of false or background color change due to reactivity of the diazonium salt in the absence of leukocyte, esterase or protease.
Abstract:
A composition and method for determining the presence of leukocyte cells, esterase or protease in a test sample are disclosed. The composition contains a lactate ester having the structure ##STR1## wherein A is an alcohol blocking group, and wherein B-O- is a residue of compound B-OH and provides a detectable response when the lactate ester is hydrolyzed; and a buffer. One class of lactate ester has the structure ##STR2## wherein X is O, S or NR.sup.2, R is aryl or lower alkyl, R.sup.1 is hydrogen or lower alkyl, and R.sup.2 is hydrogen, lower alkyl or aryl.
Abstract:
A method and apparatus is provided, whereby the level of an intracellular analyte in a cell containing sample may be determined. The apparatus is comprised of a microscope with an X-Y stage, a video camera, a computer adapted to receive video images from the video camera, and a software program for controlling the apparatus in accordance with the method. The method provided performs digital image processing so as to cause undesired features of a video image obtained by the video camera to be diminished, while desired features are emphasized. A measurement of optical densities of desired features may then be used to determine the level of intracellular analyte.
Abstract:
This invention relates to a method for determining an enzyme-, an enzyme inhibitor-, an enzyme activator-, or zymogen-activity, which comprises allowing the enzyme to react with a substrate of the formula ##STR1## (wherein R.sub.1 represents an amino acid of an oligopeptide combined in the form of ester through the C-terminal carboxyl group of said amino acid or oligopeptide and R.sub.2 represents a hydrogen or bromine atom) to hydrolyze the substrate, then allowing the hydrolysis product of the formula ##STR2## to react with a FR-ITR salt [Fast Red-ITR salt (N,N'-diethyl-4-methoxymetanilamide diazonium salt)] to form a pigment, and determining the pigment.
Abstract:
Agent for the detection of esterolytic and/or proteolytic enzymes, containing (a) an amino acid ester or peptide ester of a phenol, as the chromogenic enzyme substrate, and (b) an alcohol as the substance which accelerates the enzymatic cleavage of the amino acid ester bond or peptide ester bond of component (a), characterized in that it contains a salt as the accelerating substance.
Abstract:
A NOVEL INSOLUBLE POLYMERIC DIAZONIUM SALT COLOR DEVELOPER CONSISTING OF A DIAZOTIZED AROMATIC POLYAMINE BOUND BY AN AMIDE LINKAGE TO A CATION EXCHANGE RESIN CAN BE PREPARED BY REACTING A CATION EXCHANGE RESIN CONTAINING ACID GROUPS WITH A HALOGENATING AGENT TO CONVERT SOME OF THE RESIN ACID GROUPS TO ACYL HALIDE GROUPS, REACTING THE RESULTING ACYL HALIDE GROUPS WITH AN AROMATIC POLYAMINE TO FORM A RESIN CONTAINING AMIDE LINKAGES AND FREE AROMATIC AMINO GROUPS, AND THEN DIAZOTIZING THE FREE AROMATIC AMINO GROUPS. THE RESULTING INSOLUBLE COLOR DEVELOPER CAN BE USED TO DETECT COUPLING COMPOUNDS BY FORMING COLORED REACTION PRODUCTS WITH SUCH COUPLING COMPOUNDS. THE COLOR DEVELOPER CAN ALSO BE USED TO DETECT AN ENZYME SYSTEM WHEREIN THE ENZYME CATALYZES A REACTION WITH A SUITABLE SUBSTRATE TO RELEASE A COUPLING COMPOUND WHICH WILL FORM A COLORED REACTION PRODUCT WITH THE INSOLUBLE COLOR DEVELOPER.
Abstract:
The present invention relates to the field of infectious diseases. The invention specifically relates to the diagnostic test for acute bacterial pharyngitis. The test is used in screening for Group A Beta Haemolytic Streptococcus by the identifying the presence of leukocyte esterase in the throat. The Leukocyte Esterase Throat Swab Test is compared to the Rapid Step Test for efficiency in terms of fast delivery of results.
Abstract:
The present invention relates to the field of infectious diseases. The invention specifically relates to the diagnostic test for acute bacterial pharyngitis. The test is used in screening for Group A Beta Haemolytic Streptococcus by the identifying the presence of leukocyte esterase in the throat. The Leukocyte Esterase Throat Swab Test is compared to the Rapid Step Test for efficiency in terms of fast delivery of results.
Abstract:
Disclosed is a disposable diaper that has one or more chemical reagents provided in the absorbent region of the diaper, which comes into contact with urine when a patient wearing the diaper urinates. These chemical reagents change color when they contact urine containing abnormal levels of substances, such as leukocytes, blood, glucose, nitrites, protein, ketones, bilirubin, or urobilinogen; which substances may indicate the presence of a medical abnormality. Such a color change provides a visible indication of an abnormality in the urine and thus a possible incipient medical condition, such as a urinary tract infection, diabetes mellitus, hematuria, or the like. Such a color change is easily assessed by personnel having limited medical training, allowing such personnel to screen patients for these medical conditions and refer them to the appropriate medical personnel.
Abstract:
A dry analytical element has been prepared for the assay of prostatic acid phosphatase at a pH of from about 3 to about 6.5. The element can be a single porous spreading zone or a multilayer structure. Within the element is a relatively nonhygroscopic aromatic phosphate substrate for the analyte which produces a phenol reaction product. This product is reacted with a diazonium or tetrazolium salt, also in the element, to produce a chromophore for detection. A buffer in the element maintains it at the proper pH during the assay.